The SWITCH1 trial: Proving that Lantus/Basaglar has a higher Hypocglycaemia rate than Tresiba
Let’s start with the SWITCH 1 trial. What is it? It was a Phase 3a trial to compare the hypoglycaemia benefit of the two insulins. […]
Glargine
The Basal change – II
Day number 2 of the change over to Levemir and it appears that my body sees Levemir as a more efficient insulin. Let’s start with […]
Changing Basal Insulin – I suppose it’s Biotechnology….
For a slightly different take on technology, let’s go and look at biotechnology and its relation to me. I’m diabetic and recently took the decision […]